1. Home
  2. PXED vs STTK Comparison

PXED vs STTK Comparison

Compare PXED & STTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Phoenix Education Partners Inc.

PXED

Phoenix Education Partners Inc.

HOLD

Current Price

$28.34

Market Cap

980.1M

Sector

Real Estate

ML Signal

HOLD

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$6.85

Market Cap

792.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PXED
STTK
Founded
1976
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
980.1M
792.9M
IPO Year
2025
2020

Fundamental Metrics

Financial Performance
Metric
PXED
STTK
Price
$28.34
$6.85
Analyst Decision
Buy
Buy
Analyst Count
7
7
Target Price
$44.29
$10.00
AVG Volume (30 Days)
71.8K
773.5K
Earning Date
04-07-2026
05-01-2026
Dividend Yield
3.07%
N/A
EPS Growth
N/A
53.02
EPS
1.69
N/A
Revenue
N/A
$1,000,000.00
Revenue This Year
$3.85
N/A
Revenue Next Year
$4.49
N/A
P/E Ratio
$17.73
N/A
Revenue Growth
N/A
N/A
52 Week Low
$23.52
$1.59
52 Week High
$38.19
$8.33

Technical Indicators

Market Signals
Indicator
PXED
STTK
Relative Strength Index (RSI) 58.60 44.39
Support Level $29.24 $5.87
Resistance Level $31.32 $7.75
Average True Range (ATR) 0.88 0.34
MACD 0.33 -0.12
Stochastic Oscillator 90.44 11.51

Price Performance

Historical Comparison
PXED
STTK

About PXED Phoenix Education Partners Inc.

Phoenix Education Partners Inc. is a mission-driven organization operating at the forefront of the rapidly evolving post-secondary education market. it is an online education provider and a pioneer in its field. The company benefits from the dynamic interplay between technological innovation, education, employment, and economic trends. It is focused on delivering personalized, career-relevant, and affordable education to its students through its flexible learning model, skills-aligned curriculum, and accessible tuition costs.

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

Share on Social Networks: